Merck and Pfizer to present Avelumab data in seven different cancers
Data featured contributes to growing understanding of the potential role of avelumab in treating a broad range of cancers
20-May-2016 -
Merck and Pfizer announced that avelumab presentations across seven different tumor types, including two oral presentations, will be featured at the American Society of Clinical Oncology (ASCO) Annual Meeting. The avelumab presentations, from the rapidly accelerating JAVELIN clinical development ...
avelumab
gastric cancer
lung cancer
+7